Chemokines in CNS inflammation View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

1994-2015

FUNDING AMOUNT

3725464 USD

ABSTRACT

DESCRIPTION (provided by applicant): The current application focuses on CXCR2, a chemokine receptor present both on leukocytes and parenchymal central nervous system (CNS) cells. Our preliminary findings and recent reports demonstrate that CXCR2 on circulating leukocytes is decisive with regard to the outcome of EAE or cuprizone-mediated demyelination. Our recent findings show further that CXCR2 on CNS cells also regulates myelin repair. CXCR2 is the first chemokine receptor which promotes myelin destruction and hinders myelin repair. Our studies will address the fundamental role of CXCR2 in demyelination and remyelination, by performance of the following Specific Aims: Aim 1. We will define the pathways by CXCR2 expression by leukocytes contributes to cuprizone- mediated demyelination. Hypothesis: CXCR2 promotes demyelination through recruitment of monocytes to cuprizone lesions. The vast majority of hematogenous inflammatory cells in cuprizone lesions are monocyte- derived macrophages, leading us to suggest that CXCR2 acts through macrophage recruitment. The results of our proposed experiments will define how myeloid-cell CXCR2 contributes to this process. Aim 2. We will use an in-vitro model of demyelination-remyelination to address how the presence of CXCR2 impairs remyelination. Preliminary results showed that antibody-mediated blockade or genetic absence of CXCR2 led to accelerated remyelination of brain slices in-vitro. Hypothesis: The presence of CXCR2 on oligodendrocyte progenitor cells impairs their proliferation and differentiation in demyelinated lesions. This in-vitro model recapitulates remyelination in-vivo, particularly those aspects which take place within the demyelinated lesion. This convenient, manipulable model will be used to examine the cellular and molecular basis by which CXCR2 hinders remyelination. Aim 3. We will define CNS cells whose expression of CXCR2 leads to inefficient remyelination. To address CXCR2 function in the CNS, we generated a conditional CXCR2 allele. Hypothesis: CXCR2 impairs remyelination by slowing accumulation of oligodendrocyte progenitors in lesions and hindering their proliferation and differentiation. Mice harboring a conditional CXCR2 allele will be crossed with available mice expressing cre-ER(T2) in individual cell types, allowing efficient lineage-specific, inducible deletion. We will analyze cuprizone-mediated demyelination and remyelination to probe how CXCR2 expression in CNS cells regulates this process. These studies will provide essential data for designing clinical trials of CXCR2 blockade in MS. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=8415550

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "amount": {
      "currency": "USD", 
      "type": "MonetaryAmount", 
      "value": "3725464"
    }, 
    "description": "DESCRIPTION (provided by applicant): The current application focuses on CXCR2, a chemokine receptor present both on leukocytes and parenchymal central nervous system (CNS) cells. Our preliminary findings and recent reports demonstrate that CXCR2 on circulating leukocytes is decisive with regard to the outcome of EAE or cuprizone-mediated demyelination. Our recent findings show further that CXCR2 on CNS cells also regulates myelin repair. CXCR2 is the first chemokine receptor which promotes myelin destruction and hinders myelin repair. Our studies will address the fundamental role of CXCR2 in demyelination and remyelination, by performance of the following Specific Aims: Aim 1. We will define the pathways by CXCR2 expression by leukocytes contributes to cuprizone- mediated demyelination. Hypothesis: CXCR2 promotes demyelination through recruitment of monocytes to cuprizone lesions. The vast majority of hematogenous inflammatory cells in cuprizone lesions are monocyte- derived macrophages, leading us to suggest that CXCR2 acts through macrophage recruitment. The results of our proposed experiments will define how myeloid-cell CXCR2 contributes to this process. Aim 2. We will use an in-vitro model of demyelination-remyelination to address how the presence of CXCR2 impairs remyelination. Preliminary results showed that antibody-mediated blockade or genetic absence of CXCR2 led to accelerated remyelination of brain slices in-vitro. Hypothesis: The presence of CXCR2 on oligodendrocyte progenitor cells impairs their proliferation and differentiation in demyelinated lesions. This in-vitro model recapitulates remyelination in-vivo, particularly those aspects which take place within the demyelinated lesion. This convenient, manipulable model will be used to examine the cellular and molecular basis by which CXCR2 hinders remyelination. Aim 3. We will define CNS cells whose expression of CXCR2 leads to inefficient remyelination. To address CXCR2 function in the CNS, we generated a conditional CXCR2 allele. Hypothesis: CXCR2 impairs remyelination by slowing accumulation of oligodendrocyte progenitors in lesions and hindering their proliferation and differentiation. Mice harboring a conditional CXCR2 allele will be crossed with available mice expressing cre-ER(T2) in individual cell types, allowing efficient lineage-specific, inducible deletion. We will analyze cuprizone-mediated demyelination and remyelination to probe how CXCR2 expression in CNS cells regulates this process. These studies will provide essential data for designing clinical trials of CXCR2 blockade in MS.", 
    "endDate": "2015-01-31T00:00:00Z", 
    "funder": {
      "id": "https://www.grid.ac/institutes/grid.416870.c", 
      "type": "Organization"
    }, 
    "id": "sg:grant.2557640", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "2557640"
        ]
      }, 
      {
        "name": "nih_id", 
        "type": "PropertyValue", 
        "value": [
          "R01NS032151"
        ]
      }
    ], 
    "inLanguage": [
      "en"
    ], 
    "keywords": [
      "results", 
      "place", 
      "leukocytes", 
      "ms", 
      "available mouse", 
      "inducible deletion", 
      "process", 
      "presence", 
      "hematogenous inflammatory cells", 
      "Aim 1", 
      "Aim 2", 
      "monocyte- derived macrophages", 
      "cells", 
      "performance", 
      "blockade", 
      "oligodendrocyte progenitor cells", 
      "molecular basis", 
      "recruitment", 
      "Specific Aims", 
      "cuprizone-", 
      "CXCR2 function", 
      "proliferation", 
      "vitro model", 
      "manipulable model", 
      "EAE", 
      "demyelination", 
      "experiments", 
      "Cre-ER(T2", 
      "applicants", 
      "preliminary findings", 
      "oligodendrocyte progenitors", 
      "description", 
      "current applications", 
      "RECENT FINDINGS", 
      "mice", 
      "pathway", 
      "vast majority", 
      "efficient lineage", 
      "remyelination", 
      "CNS inflammation", 
      "recent reports", 
      "outcome", 
      "genetic absence", 
      "conditional CXCR2 allele", 
      "preliminary results", 
      "cuprizone", 
      "Aim 3", 
      "inefficient remyelination", 
      "fundamental role", 
      "first chemokine receptor", 
      "myelin destruction", 
      "myelin repair", 
      "differentiation", 
      "hypothesis", 
      "antibodies", 
      "brain slices", 
      "essential data", 
      "vitro", 
      "macrophage recruitment", 
      "parenchymal central nervous system", 
      "CXCR2 expression", 
      "chemokines", 
      "CXCR2", 
      "vivo", 
      "demyelinated lesions", 
      "monocytes", 
      "accumulation", 
      "clinical trials", 
      "chemokine receptor present", 
      "cuprizone lesions", 
      "individual cell types", 
      "lesions", 
      "myeloid-cell CXCR2", 
      "CNS cells", 
      "aspects", 
      "demyelination-remyelination", 
      "expression", 
      "regard", 
      "CXCR2 blockade", 
      "study"
    ], 
    "name": "Chemokines in CNS inflammation", 
    "recipient": [
      {
        "id": "https://www.grid.ac/institutes/grid.254293.b", 
        "type": "Organization"
      }, 
      {
        "affiliation": {
          "id": "https://www.grid.ac/institutes/grid.254293.b", 
          "name": "CLEVELAND CLINIC LERNER COM-CWRU", 
          "type": "Organization"
        }, 
        "familyName": "RANSOHOFF", 
        "givenName": "RICHARD M.", 
        "id": "sg:person.015220511077.85", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.015220511077.85", 
        "roleName": "PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.2557640"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2019-03-07T12:00", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_11.xml.gz", 
    "startDate": "1994-05-01T00:00:00Z", 
    "type": "MonetaryGrant", 
    "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=8415550"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2557640'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2557640'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2557640'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2557640'


 

This table displays all metadata directly associated to this object as RDF triples.

124 TRIPLES      19 PREDICATES      102 URIs      94 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:grant.2557640 schema:about anzsrc-for:2211
2 schema:amount Nb957928d0eaa43819c8d61724b7990ec
3 schema:description DESCRIPTION (provided by applicant): The current application focuses on CXCR2, a chemokine receptor present both on leukocytes and parenchymal central nervous system (CNS) cells. Our preliminary findings and recent reports demonstrate that CXCR2 on circulating leukocytes is decisive with regard to the outcome of EAE or cuprizone-mediated demyelination. Our recent findings show further that CXCR2 on CNS cells also regulates myelin repair. CXCR2 is the first chemokine receptor which promotes myelin destruction and hinders myelin repair. Our studies will address the fundamental role of CXCR2 in demyelination and remyelination, by performance of the following Specific Aims: Aim 1. We will define the pathways by CXCR2 expression by leukocytes contributes to cuprizone- mediated demyelination. Hypothesis: CXCR2 promotes demyelination through recruitment of monocytes to cuprizone lesions. The vast majority of hematogenous inflammatory cells in cuprizone lesions are monocyte- derived macrophages, leading us to suggest that CXCR2 acts through macrophage recruitment. The results of our proposed experiments will define how myeloid-cell CXCR2 contributes to this process. Aim 2. We will use an in-vitro model of demyelination-remyelination to address how the presence of CXCR2 impairs remyelination. Preliminary results showed that antibody-mediated blockade or genetic absence of CXCR2 led to accelerated remyelination of brain slices in-vitro. Hypothesis: The presence of CXCR2 on oligodendrocyte progenitor cells impairs their proliferation and differentiation in demyelinated lesions. This in-vitro model recapitulates remyelination in-vivo, particularly those aspects which take place within the demyelinated lesion. This convenient, manipulable model will be used to examine the cellular and molecular basis by which CXCR2 hinders remyelination. Aim 3. We will define CNS cells whose expression of CXCR2 leads to inefficient remyelination. To address CXCR2 function in the CNS, we generated a conditional CXCR2 allele. Hypothesis: CXCR2 impairs remyelination by slowing accumulation of oligodendrocyte progenitors in lesions and hindering their proliferation and differentiation. Mice harboring a conditional CXCR2 allele will be crossed with available mice expressing cre-ER(T2) in individual cell types, allowing efficient lineage-specific, inducible deletion. We will analyze cuprizone-mediated demyelination and remyelination to probe how CXCR2 expression in CNS cells regulates this process. These studies will provide essential data for designing clinical trials of CXCR2 blockade in MS.
4 schema:endDate 2015-01-31T00:00:00Z
5 schema:funder https://www.grid.ac/institutes/grid.416870.c
6 schema:identifier N4b3eb0906b9e41b1a4b358084d1cd1de
7 N57769970034841ce8458e75fca351996
8 schema:inLanguage en
9 schema:keywords Aim 1
10 Aim 2
11 Aim 3
12 CNS cells
13 CNS inflammation
14 CXCR2
15 CXCR2 blockade
16 CXCR2 expression
17 CXCR2 function
18 Cre-ER(T2
19 EAE
20 RECENT FINDINGS
21 Specific Aims
22 accumulation
23 antibodies
24 applicants
25 aspects
26 available mouse
27 blockade
28 brain slices
29 cells
30 chemokine receptor present
31 chemokines
32 clinical trials
33 conditional CXCR2 allele
34 cuprizone
35 cuprizone lesions
36 cuprizone-
37 current applications
38 demyelinated lesions
39 demyelination
40 demyelination-remyelination
41 description
42 differentiation
43 efficient lineage
44 essential data
45 experiments
46 expression
47 first chemokine receptor
48 fundamental role
49 genetic absence
50 hematogenous inflammatory cells
51 hypothesis
52 individual cell types
53 inducible deletion
54 inefficient remyelination
55 lesions
56 leukocytes
57 macrophage recruitment
58 manipulable model
59 mice
60 molecular basis
61 monocyte- derived macrophages
62 monocytes
63 ms
64 myelin destruction
65 myelin repair
66 myeloid-cell CXCR2
67 oligodendrocyte progenitor cells
68 oligodendrocyte progenitors
69 outcome
70 parenchymal central nervous system
71 pathway
72 performance
73 place
74 preliminary findings
75 preliminary results
76 presence
77 process
78 proliferation
79 recent reports
80 recruitment
81 regard
82 remyelination
83 results
84 study
85 vast majority
86 vitro
87 vitro model
88 vivo
89 schema:name Chemokines in CNS inflammation
90 schema:recipient N127cca1aebde481fa6899d9da132aa96
91 sg:person.015220511077.85
92 https://www.grid.ac/institutes/grid.254293.b
93 schema:sameAs https://app.dimensions.ai/details/grant/grant.2557640
94 schema:sdDatePublished 2019-03-07T12:00
95 schema:sdLicense https://scigraph.springernature.com/explorer/license/
96 schema:sdPublisher N476e9add692f47ef89a9ef7daa70cf24
97 schema:startDate 1994-05-01T00:00:00Z
98 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=8415550
99 sgo:license sg:explorer/license/
100 sgo:sdDataset grants
101 rdf:type schema:MonetaryGrant
102 N127cca1aebde481fa6899d9da132aa96 schema:member sg:person.015220511077.85
103 schema:roleName PI
104 rdf:type schema:Role
105 N476e9add692f47ef89a9ef7daa70cf24 schema:name Springer Nature - SN SciGraph project
106 rdf:type schema:Organization
107 N4b3eb0906b9e41b1a4b358084d1cd1de schema:name dimensions_id
108 schema:value 2557640
109 rdf:type schema:PropertyValue
110 N57769970034841ce8458e75fca351996 schema:name nih_id
111 schema:value R01NS032151
112 rdf:type schema:PropertyValue
113 Nb957928d0eaa43819c8d61724b7990ec schema:currency USD
114 schema:value 3725464
115 rdf:type schema:MonetaryAmount
116 anzsrc-for:2211 schema:inDefinedTermSet anzsrc-for:
117 rdf:type schema:DefinedTerm
118 sg:person.015220511077.85 schema:affiliation https://www.grid.ac/institutes/grid.254293.b
119 schema:familyName RANSOHOFF
120 schema:givenName RICHARD M.
121 rdf:type schema:Person
122 https://www.grid.ac/institutes/grid.254293.b schema:name CLEVELAND CLINIC LERNER COM-CWRU
123 rdf:type schema:Organization
124 https://www.grid.ac/institutes/grid.416870.c schema:Organization
 




Preview window. Press ESC to close (or click here)


...